PeterLabs Holdings Bhd (KLSE:0171) — Market Cap & Net Worth
Market Cap & Net Worth: PeterLabs Holdings Bhd (0171)
PeterLabs Holdings Bhd (KLSE:0171) has a market capitalization of $15.55 Million (RM61.92 Million) as of September 17, 2026. Listed on the KLSE stock exchange, this Malaysia-based company holds position #25972 globally and #749 in its home market, demonstrating a -2.17% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PeterLabs Holdings Bhd's stock price RM0.23 by its total outstanding shares 275213890 (275.21 Million). Also see PeterLabs Holdings Bhd (0171) total assets for a full breakdown of the balance sheet.
PeterLabs Holdings Bhd Market Cap History: 2015 to 2026
PeterLabs Holdings Bhd's market capitalization history from 2015 to 2026. Data shows growth from $16.69 Million to $15.55 Million (1.32% CAGR). Also see how efficiently does PeterLabs Holdings Bhd generate cash for how efficiently the company converts equity into cash flow.
PeterLabs Holdings Bhd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PeterLabs Holdings Bhd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 0171 share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.05x
PeterLabs Holdings Bhd's market cap is 0.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.74x
PeterLabs Holdings Bhd's market cap is 5.74 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $16.69 Million | $73.48 Million | $3.34 Million | 0.23x | 5.00x |
| 2016 | $14.88 Million | $83.58 Million | $3.33 Million | 0.18x | 4.46x |
| 2017 | $17.98 Million | $94.73 Million | $4.01 Million | 0.19x | 4.49x |
| 2018 | $17.35 Million | $90.42 Million | $3.80 Million | 0.19x | 4.57x |
| 2019 | $12.93 Million | $96.23 Million | $4.28 Million | 0.13x | 3.03x |
| 2020 | $15.44 Million | $80.03 Million | $3.89 Million | 0.19x | 3.97x |
| 2021 | $14.46 Million | $183.82 Million | $5.48 Million | 0.08x | 2.64x |
| 2022 | $13.21 Million | $161.63 Million | $3.60 Million | 0.08x | 3.67x |
| 2023 | $14.23 Million | $186.21 Million | $1.39 Million | 0.08x | 10.27x |
| 2024 | $13.13 Million | $242.21 Million | $2.29 Million | 0.05x | 5.74x |
Competitor Companies of 0171 by Market Capitalization
Companies near PeterLabs Holdings Bhd in the global market cap rankings as of September 17, 2026. Review 0171 intangible-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to PeterLabs Holdings Bhd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #631 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #636 globally with a market cap of $43.34 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #672 globally with a market cap of $40.69 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #631 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.00 |
| #636 | GALDERMA GROUP AG | NYSE:GALDY | $43.34 Billion | $37.18 |
| #672 | Haleon plc | NYSE:HLN | $40.69 Billion | $9.24 |
PeterLabs Holdings Bhd Historical Marketcap From 2015 to 2026
Between 2015 and today, PeterLabs Holdings Bhd's market cap moved from $16.69 Million to $ 15.55 Million, with a yearly change of 1.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | RM15.55 Million | -8.16% |
| 2025 | RM16.93 Million | +28.95% |
| 2024 | RM13.13 Million | -7.72% |
| 2023 | RM14.23 Million | +7.69% |
| 2022 | RM13.21 Million | -8.60% |
| 2021 | RM14.46 Million | -6.40% |
| 2020 | RM15.44 Million | +19.39% |
| 2019 | RM12.93 Million | -25.45% |
| 2018 | RM17.35 Million | -3.50% |
| 2017 | RM17.98 Million | +20.85% |
| 2016 | RM14.88 Million | -10.85% |
| 2015 | RM16.69 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of PeterLabs Holdings Bhd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $15.55 Million USD |
| MoneyControl | $15.55 Million USD |
| MarketWatch | $15.55 Million USD |
| marketcap.company | $15.55 Million USD |
| Reuters | $15.55 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About PeterLabs Holdings Bhd
PeterLabs Holdings Berhad, an investment holding company, engages in manufacturing, distribution, trading, and export of animal health and nutrition products in Malaysia and internationally. The company operates through three segments: Manufacturing, Trading, and Others. It offers biosecurity products and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceutic… Read more